US Broker Ratings

Certara, Inc. (CERT) Stock Analysis: Exploring a 38.74% Potential Upside

Certara, Inc. (NASDAQ: CERT), a key player in the health information services sector, is capturing the attention of investors with a potential upside of 38.74% based on its current stock..

Opko Health, Inc. (OPK) Investor Outlook: Assessing a Potential 177.99% Upside

Investors eyeing Opko Health, Inc. (NASDAQ: OPK) might find the diagnostics and pharmaceuticals company an intriguing proposition, particularly given the potential upside of nearly 178%. With a market capitalization of..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Unpacking a 373% Potential Upside in Biotech

Janux Therapeutics, Inc. (NASDAQ: JANX), a prominent player in the biotechnology sector, is currently positioned as an attractive prospect for investors with a notable potential upside of 373.58%. This San..

Concentra Group Holdings Parent (CON) Stock Analysis: 46% Upside Potential in the Healthcare Sector

For investors eyeing opportunities in the healthcare sector, Concentra Group Holdings Parent (CON) presents a compelling case with its notable 46.09% potential upside. With a focus on occupational health services,..

10x Genomics, Inc. (TXG) Investor Outlook: Navigating Mixed Analyst Ratings Amid a Promising Sector

10x Genomics, Inc. (NASDAQ: TXG), a prominent player in the healthcare sector, specifically within the health information services industry, has garnered significant attention from investors. Headquartered in Pleasanton, California, the..

Guardian Pharmacy Services, Inc (GRDN) Stock Analysis: A Promising Healthcare Play with 9% Upside Potential

Guardian Pharmacy Services, Inc. (NASDAQ: GRDN), a key player in the healthcare sector, provides innovative pharmacy services specifically designed for long-term care facilities in the United States. With a market..

NewAmsterdam Pharma (NAMS) Stock Analysis: Unveiling a 43.88% Potential Upside in the Biotech Sector

NewAmsterdam Pharma Company N.V. (NASDAQ: NAMS), headquartered in Naarden, the Netherlands, is making waves in the biotechnology sector with its ambitious pursuits in metabolic disease therapies. The company’s innovative approach..

Arrowhead Pharmaceuticals, Inc. (ARWR)

⚠️ No article content returned.

..

Centessa Pharmaceuticals (CNTA) Stock Analysis: A 69% Upside Potential in Biotech Innovation

Centessa Pharmaceuticals plc (NASDAQ: CNTA), a UK-based biotechnology firm, has captured investor attention with its promising pipeline and substantial potential upside of 69.42%. Positioned within the healthcare sector, Centessa focuses..

LeMaitre Vascular, Inc. (LMAT) Stock Analysis: Navigating a 26% Upside Potential in the Medical Devices Sector

LeMaitre Vascular, Inc. (NASDAQ: LMAT), a prominent player in the healthcare sector, specializes in medical instruments and supplies, particularly for vascular surgery. Headquartered in Burlington, Massachusetts, this company has established..

Aveanna Healthcare Holdings Inc (AVAH): Investor Outlook Reveals 29.56% Potential Upside in Healthcare Sector

Aveanna Healthcare Holdings Inc. (NASDAQ: AVAH), a prominent player in the healthcare sector, stands out as a diversified home care platform company offering a range of pediatric and adult healthcare..

AtriCure, Inc. (ATRC) Stock Analysis: Strong Buy Ratings with 29% Upside Potential

AtriCure, Inc. (NASDAQ: ATRC), a prominent player in the healthcare sector, specifically within the medical instruments and supplies industry, has been gaining significant attention from investors. Based in Mason, Ohio,..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: Exploring a 30% Upside Potential in the Biotech Sector

MoonLake Immunotherapeutics (MLTX), a Swiss-based clinical-stage biotechnology company, is attracting attention in the healthcare sector with its innovative approach to treating inflammatory diseases. Despite being a relatively new entrant in..

Celldex Therapeutics (CLDX) Stock Analysis: Biotechnology Innovator with Over 100% Upside Potential

Celldex Therapeutics, Inc. (NASDAQ: CLDX), a biopharmaceutical company specializing in the development of therapeutic antibodies, is capturing the attention of investors with its significant potential upside. Currently priced at $25.60,..

Indivior PLC (INDV) Stock Analysis: A Prescription for Growth with 4.43% Upside

Indivior PLC (INDV), a notable player in the healthcare sector, has carved a niche in the specialty and generic drug manufacturing industry. With a focus on addressing the critical challenges..

Travere Therapeutics, Inc. (TVTX) Stock Analysis: Exploring a 10.77% Upside Potential in the Biotech Sector

In the dynamic world of biotechnology, Travere Therapeutics, Inc. (NASDAQ: TVTX) is making a name for itself with its innovative approach to treating rare kidney and metabolic diseases. For investors..

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 19.81% Potential Upside in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA) is an intriguing player in the healthcare sector, specifically within the medical instruments and supplies industry. With a market capitalization of $1.64 billion, Azenta offers a..

Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Exploring a 61.93% Upside Potential in Biotech

Edgewise Therapeutics, Inc. (NASDAQ: EWTX), a biopharmaceutical company at the forefront of muscle disorder therapeutics, presents an intriguing opportunity for investors willing to navigate the volatile waters of biotechnology. Headquartered..

Ardent Health, Inc. (ARDT) Stock Analysis: Unveiling a Potential 52.87% Upside for Investors

Ardent Health, Inc. (NASDAQ: ARDT), a key player in the U.S. healthcare sector, is drawing investor attention due to its robust potential upside of 52.87%. Situated in the medical care..

AdaptHealth Corp. (AHCO) Stock Report: Analysts See a 35% Upside Potential

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector, specializes in the distribution of home medical equipment (HME) and related services across the United States. With a current..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds